Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trialYu‐Pei Chen, Jun Ma, Feng Jin et al.|The Lancet|2021Cited by 234
Prognostic Role of M6A-Associated Immune Genes and Cluster-Related Tumor Microenvironment Analysis: A Multi-Omics Practice in Stomach AdenocarcinomaNa Luo, Guangyuan Hu, Min Fu et al.|Frontiers in Cell and Developmental Biology|2022Cited by 8